Risk Factors for Laryngectomy for Dysfunctional Larynx After Organ Preservation Protocols: A Case-Control Analysis
- PMID: 32806995
- DOI: 10.1177/0194599820947702
Risk Factors for Laryngectomy for Dysfunctional Larynx After Organ Preservation Protocols: A Case-Control Analysis
Abstract
Objective: (1) To identify factors associated with severe dysfunctional larynx leading to total laryngectomy after curative treatment of head and neck squamous cell carcinoma and (2) to describe swallowing and voice outcomes.
Study design: Retrospective single-institution case-control study.
Setting: Tertiary care referral center.
Methods: A 10-year chart review was performed for patients who had previously undergone radiation or chemoradiation for head and neck mucosal squamous cell carcinoma and planned to undergo total laryngectomy for dysfunctional larynx, as well as a control group of matched patients. Controls were patients who had undergone radiation or chemoradiation for mucosal squamous cell carcinoma but did not have severe dysfunction warranting laryngectomy; these were matched to cases by tumor subsite, T stage, and time from last treatment to video swallow study. Main outcomes assessed were postoperative diet, alaryngeal voice, pharyngeal dilations, and complications.
Results: Twenty-six patients were scheduled for laryngectomy for dysfunctional larynx, of which 23 underwent surgery. Originally treated tumor subsites included the larynx, oropharynx, hypopharynx, oral cavity, and a tumor of unknown origin. The median time from end of cancer treatment to laryngectomy was 11.5 years. All cases were feeding tube or tracheostomy dependent or both prior to laryngectomy. As compared with matched controls, cases were significantly less likely to have undergone IMRT (intensity-modified radiotherapy) and more likely to have pulmonary comorbidities. Eighty-nine percent of cases with follow-up achieved functional alaryngeal voice, and all were able to have oral intake.
Conclusion: Non-IMRT approaches and pulmonary comorbidities are associated with laryngectomy for dysfunction after radiation or chemoradiation.
Keywords: aspiration; dysfunctional larynx; dysphagia; laryngectomy.
Similar articles
-
Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1395-9. doi: 10.1016/j.ijrobp.2005.05.004. Epub 2005 Aug 8. Int J Radiat Oncol Biol Phys. 2005. PMID: 16087298 Clinical Trial.
-
Total laryngectomy for a dysfunctional larynx after (chemo)radiotherapy.Arch Otolaryngol Head Neck Surg. 2012 Jun;138(6):548-55. doi: 10.1001/archoto.2012.862. Arch Otolaryngol Head Neck Surg. 2012. PMID: 22710506
-
Speech and swallowing outcomes after laryngectomy for the dysfunctional irradiated larynx.Eur Arch Otorhinolaryngol. 2020 May;277(5):1459-1465. doi: 10.1007/s00405-020-05809-y. Epub 2020 Jan 27. Eur Arch Otorhinolaryngol. 2020. PMID: 31989269
-
Functional laryngectomy for the dysfunctional larynx: indications and outcomes in setting of prior chemoradiotherapy.Curr Opin Otolaryngol Head Neck Surg. 2021 Dec 1;29(6):473-478. doi: 10.1097/MOO.0000000000000757. Curr Opin Otolaryngol Head Neck Surg. 2021. PMID: 34535008 Review.
-
Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.J Clin Oncol. 2018 Apr 10;36(11):1143-1169. doi: 10.1200/JCO.2017.75.7385. Epub 2017 Nov 27. J Clin Oncol. 2018. PMID: 29172863
Cited by
-
Intensity-Modulated Radiotherapy (IMRT) following Conservative Surgery of the Supraglottic Region: Impact on Functional Outcomes.Cancers (Basel). 2022 May 24;14(11):2600. doi: 10.3390/cancers14112600. Cancers (Basel). 2022. PMID: 35681579 Free PMC article.
-
Risk Factors for Functional Outcomes in Advanced Laryngeal Squamous Cell Carcinoma.Laryngoscope. 2023 Mar;133(3):594-600. doi: 10.1002/lary.30166. Epub 2022 May 25. Laryngoscope. 2023. PMID: 35611799 Free PMC article.
-
Late laryngeal dysfunction in head and neck cancer survivors.Laryngoscope Investig Otolaryngol. 2023 Jul 31;8(5):1272-1278. doi: 10.1002/lio2.1128. eCollection 2023 Oct. Laryngoscope Investig Otolaryngol. 2023. PMID: 37899877 Free PMC article.
-
Outcomes for Organ Preservation with Chemoradiation Therapy for T4 Larynx and Hypopharynx Cancer.Laryngoscope. 2023 May;133(5):1138-1145. doi: 10.1002/lary.30279. Epub 2022 Jul 8. Laryngoscope. 2023. PMID: 35801573 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials